Accomplished Clinical Operations Leader with 20 years of experience managing global Phase I–III oncology and immuno-oncology programs from Pre-IND to NDA stages. Delivered significant reductions in timelines and budget savings across multi-million dollar portfolios. Fostered inspection-ready trials through strategic collaboration with leadership and regulatory teams, overseeing CROs and vendors to ensure timely, submission-ready data.
Overview
21
21
years of professional experience
Work History
Executive Director, Clinical Operations
Trishula Therapeutics, Inc
South San Francisco, CA
03.2023 - Current
Spin-out from Tizona
Sr. Director, Clinical Operations
Trishula Therapeutics, Inc
South San Francisco, CA
08.2020 - 03.2023
Leads global Clinical Operations for an oncology/immuno-oncology portfolio from program planning through database lock and submission readiness.
Sets strategy, builds internal processes, governs CROs/vendors, and steers cross-functional execution, budget, quality, and risk management.
Delivered portfolio critical path and acceleration plans, resulting in 8-week earlier enrollment timeline across Phase 1/2 studies.
Established vendor governance with KPIs/KRIs, reducing protocol deviations and query aging through centralized data review while ensuring quality data oversight.
Re-forecasted and optimized CRO/vendor budgets and performance, achieving maximum annual efficiencies.
Simplified tech stack (EDC, IRT integrations); trimmed database-lock and site closures cycle time.
Built scalable processes (start-up playbooks, risk-based quality, issue management) that shortened timelines ~15%.
Spin-out from Tizona
Director, Clinical Operations
Tizona Therapeutics, Inc
South San Francisco, CA
03.2019 - 08.2020
Director, Clinical Operations
Adverum Biotechnologies
Menlo Park, CA
10.2017 - 01.2019
Accountable for clinical program execution: vendor oversight, resource planning, timeline/budget management, and compliance.
Provided operational leadership to translate program strategy into executable plans and lifecycle delivery, ensuring alignment with organizational goals.
Collaborated on protocol and clinical document development, facilitating IND submissions and achieving expedited designations/briefing packages.
Led study teams, coaching talent to enhance skills and managing performance to meet project milestones.
Partnered with Quality to refine SOPs, mitigate compliance risks, and conduct vendor audits.
Director, Clinical Operations
Iovance Biotherapeutics, Inc
San Carlos, CA
09.2016 - 10.2017
Led operational planning and execution for oncology program, ensuring adherence to timeline, budget, and quality standards.
Negotiated and managed CROs/vendors, enhancing investigator engagement and site performance.
Chaired cross-functional study forums, managing risks and issues to resolution.
Drove process and SOP improvements across the department.
Authored core study documents (protocol, ICF, monitoring/data plans) and governed change control.
Associate Director, Clinical Operations
Pharmacyclics LLC (An AbbVie Co.)
Sunnyvale, CA
07.2015 - 09.2016
Program lead for a late-stage oncology portfolio; accountable for planning, resources, milestones, fiscal management, and compliant execution.
Managed and developed team of 7, directing CTLs and study staff to ensure project alignment and compliance.
Partnered with project management, clinical science, research, and supply to strategize and mitigate risks across programs.
Established training priorities with Therapeutic ED to ensure role-based, GCP-aligned competency.
Conducted sponsor oversight of CROs/vendors; participated in audits and inspections.
Led department initiatives to modernize processes and tools.
Directed study management for multiple trials, including a pivotal Phase 1b/2 CLL study culminating in accelerated FDA approval.
Managed delivery from start-up through close-out; served as primary escalation point for sites and vendors.
Developed study and vendor specifications (protocol, ICF, CRFs, monitoring plans, EDC/IRT) and supported CSR and NDA deliverables.
Executed internal audits, mock inspections, and remediation plans to enhance inspection readiness and maintain TMF quality.
Served as subject matter expert during FDA inspection.
Sr. Clinical Research Associate
Nektar Therapeutics, Inc.
San Francisco, CA
07.2009 - 11.2011
Led Phase II oncology trials, ensuring adherence to regulatory standards and timelines.
Associate Director and Country Lead-Clinical Trial Operations at Pi Health Ltd.Associate Director and Country Lead-Clinical Trial Operations at Pi Health Ltd.